Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes improve symptoms and fertility in hyper-androgenic women.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Hyperandrogenism and insulin resistance in PCOS-like rats can lead to pregnancy complications due to increased cell death in the uterus and placenta.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Women with high androgen levels may have more severe COVID-19 symptoms.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Most patients improved with oral contraceptives, but some needed additional treatment.

Measuring certain hormones can help predict metabolic risk in women with PCOS.